We are always introducing new clinical trials across our international network. If you can’t find what you are looking for please don’t hesitate to speak to your doctor to learn more, or contact us here.
Use the search function below to find a clinical trial that may suit you and your cancer diagnosis
78278343PCR1003
78278343PCR1003: A Study of JNJ-78278343 in Combination With Either JNJ-63723283 (Cetrelimab), Taxane Chemotherapy, or Androgen Receptor Pathway Inhibitors for Metastatic Castration-Resistant Prostate Cancer
Locations
Adelaide (Kurralta Park)
Diagnosis
Prostate cancer
Open for recruitment
View Trial
IL Believe
A Phase 1/2, Open-label, Dose Escalation and Dose Expansion Study to Investigate the Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab, Standard of Care Chemotherapy, or TransCon TLR7/8 Agonist, or in Combination With Pembrolizumab and Standard of Care Chemotherapy, in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies
Locations
Farrer Park
Diagnosis
Advanced solid tumours, Cervical cancer, Lung cancer, Skin cancer – melanoma
Open for recruitment
View Trial
DeLLphi-306
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Tarlatamab Therapy in Subjects With Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Who Have Not Progressed Following Concurrent Chemoradiation Therapy
Locations
Mount Alvernia
Diagnosis
Lung cancer
Open for recruitment
View Trial
pionERA
A Phase III Randomized, Open-Label Study Evaluating Efficacy and Safety of Giredestrant Compared With Fulvestrant, Both Combined With a CDK4/6 Inhibitor, in Patients With Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer With Resistance to Prior Adjuvant Endocrine Therapy
Locations
Gleneagles, Farrer Park
Diagnosis
Breast cancer
Open for recruitment
View Trial
INAVO122
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo As Maintenance Therapy After First Line Induction Therapy in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
Locations
Farrer Park
Diagnosis
Breast cancer
Open for recruitment
View Trial
CAMBRIA-1
A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Extended Therapy With Camizestrant Versus Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) in Patients With ER+/HER2- Early Breast Cancer
Locations
Farrer Park
Diagnosis
Breast cancer
Open for recruitment
View Trial
ABCPro
ABCPro: Trial is evaluating a new online service for managing self-reported symptoms by people with advanced breast cancer
Locations
Bowen Icon Cancer Centre
Diagnosis
Breast cancer
Open for recruitment
View Trial
AK138D1-101
AK138D1-101: A Phase I Study of AK138D1 in the Treatment of Advanced Solid Tumors
Locations
South Brisbane
Diagnosis
Advanced solid tumours
Open for recruitment
View Trial
ALLG NBCR
ALLG NBCR: Australasian Leukaemia and Lymphoma Group National Blood Cancer Registry
Locations
Wesley
Diagnosis
Leukaemia
Open for recruitment
View Trial
AMLM22/D1
AMLM22/D1: The International Acute myeloid leukaemia (AML) Platform Consortium (IAPC) trial is a randomised, multi-arm study platform to compare the efficacy of experimental therapies versus standard of care in patients with acute myeloid leukaemia in first complete remission
Locations
South Brisbane, Wesley, Chermside, Southport
Diagnosis
Leukaemia
Open for recruitment
View Trial
AMT-116-01
AMT-116-01: AMT-116 in Patients With Advanced Solid Tumors
Locations
South Brisbane
Diagnosis
Advanced solid tumours
Open for recruitment
View Trial
AMT-253-01
AMT-253-01: AMT-253 in Patients With Selected Advanced Solid Tumours
Locations
South Brisbane
Diagnosis
Advanced solid tumours
Open for recruitment
View Trial
REGENERON_ R1979-ONC-1625
An open-label study to assess the anti-tumor activity and safety of REGN1979, an Anti-CD20 X Anti-CD3 bispecific antibody, in patients with relapsed or refractory B-cell non-hodgkin lymphoma
Locations
Farrer Park
Diagnosis
Lymphoma – B-cell Non Hodgkin’s
Open for recruitment
View Trial
INBRX-106
An Open-Label, Multicenter, First-in-Human, Dose-Escalation, Multicohort, Phase 1/2 Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab in Subjects With Locally Advanced or Metastatic Solid Tumors
Locations
Farrer Park, Mount Alvernia
Diagnosis
Advanced solid tumours
Open for recruitment
View Trial
Trofuse-010
An Open-label, Randomized Phase 3 Study of MK-2870 as a Single Agent and in Combination with Pembrolizumab Versus Treatment of Physician’s Choice in Participants with HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer
Locations
Mount Alvernia
Diagnosis
Breast cancer
Open for recruitment
View Trial
ANZadapt / ANZUP 2101
ANZadapt / ANZUP 2101: Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC
Locations
Adelaide (Kurralta Park)
Diagnosis
Prostate cancer
Open for recruitment
View Trial
ARC-20
ARC-20: A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
Locations
Adelaide (Kurralta Park)
Diagnosis
Advanced solid tumours
Open for recruitment
View Trial
ASPEN-06 / AT148006
ASPEN-06 / AT148006: A Study of Evorpacept (ALX148) in Patients with Advanced HER2+ Gastric Cancer
Locations
Southport
Diagnosis
Gastric / gastroesophageal cancer
Open for recruitment
View Trial
ASPIRE / CL-SBP-101-04
ASPIRE / CL-SBP-101-04: Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
Locations
Adelaide (Kurralta Park)
Diagnosis
Pancreatic cancer
Trial on hold
View Trial
ATOMIC
ATOMIC: Retrospective evaluation of predictive relevance of Manganese concentrations for the radio-responsiveness of solid cancers
Locations
Greenslopes
Diagnosis
Advanced solid tumours
Open for recruitment
View Trial
AWT020-001
AWT020-001: Phase 1 Study of AWT020 in Advanced Cancer
Locations
South Brisbane
Diagnosis
Advanced solid tumours
Open for recruitment
View Trial
BBI-TP-3654-102
BBI-TP-3654-102: A Study of Oral Nuvisertib (TP-3654) in Patients with Myelofibrosis
Locations
Adelaide (Windsor Gardens)
Diagnosis
Myeloproliferative disorders
Open for recruitment
View Trial
BG-C137-101
BG-C137-101: A First-in-Human Study of BG-C137, an Anti-FGFR2b Antibody Drug Conjugate, in Participants With Advanced Solid Tumors
Locations
South Brisbane
Diagnosis
Advanced solid tumours
Open for recruitment
View Trial
BGB-24714-101
BGB-24714-101: A Study of BGB-24714 as Monotherapy and With Combination Therapies in Participants With Solid Tumors
Locations
South Brisbane
Diagnosis
Advanced solid tumours
Trial on hold
View Trial
BGB-3111-LTE1
BGB-3111-LTE1: Long-term Extension Study of Zanubrutinib (BGB-3111) Regimens in Participants With B-cell Malignancies
Locations
Wesley
Diagnosis
B-cell malignancies
Open for recruitment
View Trial
BGB-A317-26808-101
BGB-A317-26808-101: A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors
Locations
Adelaide (Kurralta Park)
Diagnosis
Advanced solid tumours
Open for recruitment
View Trial
BGB-A317-A3055-101
BGB-A317-A3055-101: A Study of BGB-A3055, Alone and in Combination With Tislelizumab in Participants With Selected Advanced or Metastatic Solid Tumors
Locations
South Brisbane
Diagnosis
Advanced solid tumours
Open for recruitment
View Trial
BM230-01
BM230-01: Study of BM230 in Patients With Advanced Solid Tumors
Locations
South Brisbane
Diagnosis
Advanced solid tumours
Open for recruitment
View Trial
BNT327-02
BNT327-02: Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination with Chemotherapy
Locations
Wesley
Diagnosis
Breast cancer
Open for recruitment
View Trial
BNT327-03
BNT327-03: Safety and Effectiveness of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Locations
Adelaide (Kurralta Park)
Diagnosis
Lung cancer
Open for recruitment
View Trial
BNT327-06
BNT327-06: Safety, Effectiveness, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Locations
Townsville, Adelaide (Kurralta Park)
Diagnosis
Lung cancer
Open for recruitment
View Trial
C1131003
C1131003: Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
Locations
Adelaide (Kurralta Park)
Diagnosis
Immune Thrombocytopenia (ITP)
Open for recruitment
View Trial
C2321014
C2321014: A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1)
Locations
Wesley
Diagnosis
Prostate cancer
Open for recruitment
View Trial
CLINCH / ATG-022-ST-001
CLINCH / ATG-022-ST-001: A Study of ATG-022 in Patients With Advanced/Metastatic Solid Tumors
Locations
South Brisbane
Diagnosis
Advanced solid tumours
Open for recruitment
View Trial
CS2009-101
CS2009-101: A Phase I Study of CS2009 in Participants With Advanced Solid Tumors
Locations
South Brisbane
Diagnosis
Advanced solid tumours
Open for recruitment
View Trial
DB-1303-O-1001
DB-1303-O-1001: A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
Locations
South Brisbane
Diagnosis
Advanced solid tumours
Open for recruitment
View Trial
DCC-3116-01-001
DCC-3116-01-001: A Phase 1/2 Study of DCC-3116 in Patients With RAS/MAPK Pathway Mutant Solid Tumors
Locations
Adelaide (Kurralta Park)
Diagnosis
Advanced solid tumours
Opening soon
View Trial
DECREASE
DECREASE: Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA
Locations
Epworth Richmond
Diagnosis
Prostate cancer
Open for recruitment
View Trial
DM001001
DM001001: A Study of DM001 in Patients With Advanced Solid Tumors
Locations
South Brisbane
Diagnosis
Advanced solid tumours
Open for recruitment
View Trial
DM005001
DM005001: A Study of DM001 in Patients With Advanced Solid Tumors
Locations
South Brisbane
Diagnosis
Advanced solid tumours
Open for recruitment
View Trial
Duravelo-2 / BT8009-230
Duravelo-2 / BT8009-230: Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer
Locations
Wesley
Diagnosis
Urothelial cancer
Trial on hold
View Trial
EIK1001-006
EIK1001-006: Safety and Efficacy of EIK1001-006 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma
Locations
Chermside
Diagnosis
Skin cancer – melanoma
Open for recruitment
View Trial
ELEGANT / STML-ELA-0422
ELEGANT / STML-ELA-0422: A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Locations
Southport, Wesley, Hobart, Adelaide (Kurralta Park), Townsville
Diagnosis
Breast cancer
Open for recruitment
View Trial
ERUPT
ERUPT: Urethral scarring after radiation treatment for prostate cancer
Locations
Toowoomba
Diagnosis
Prostate cancer
Open for recruitment
View Trial
EvoPAR-Prostate01 / D9723C00001
EvoPAR-Prostate01 / D9723C00001: Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician’s Choice New Hormonal Agents
Locations
Adelaide (Kurralta Park), Chermside, Townsville
Diagnosis
Prostate cancer
Open for recruitment
View Trial
EXPERT / ANZ1601
EXPERT / ANZ1601: EXamining PErsonalised Radiation Therapy for Low-risk Early Breast Cancer
Locations
Epworth Richmond
Diagnosis
Breast cancer
Open for recruitment
View Trial
FIG
FIG: Prospective, multicentre trial evaluating O-(2-[18F]-fluoroethyl)-L-tyrosine Positron Emission Tomography in Glioblastoma (FET-PET in Glioblastoma)
Locations
Wesley
Diagnosis
Brain cancer
Open for recruitment
View Trial
FPI-2265-203
FPI-2265-203: A Phase II, Open-Label, Multi-Centre Study of FPI-2265 (225Ac-PSMA-I&T) and Olaparib in Participants with Metastatic Castration Resistant Prostate Cancer (mCRPC)
Locations
Adelaide (Kurralta Park)
Diagnosis
Prostate cancer
Open for recruitment
View Trial
HARMONY / R3767-ONC-2011
HARMONY / R3767-ONC-2011: Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma
Locations
Hobart
Diagnosis
Skin cancer – melanoma
Open for recruitment
View Trial
HERTHENA-PanTumor01 / U31402-277
HERTHENA-PanTumor01 / U31402-277: A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Locations
Chermside, Hobart, Townsville
Diagnosis
Advanced solid tumours
Open for recruitment
View Trial
HMBD-001-002
HMBD-001-002: Study of an Anti-HER3 Antibody, HMBD-001, With or Without Chemotherapy in Patients With Solid Tumors Harboring an NRG1 Fusion or HER3 Mutation
Locations
South Brisbane
Diagnosis
Advanced solid tumours
Trial on hold
View Trial
HX044-I-01
HX044-I-01: HX044, FIH Study in Patients With Advanced Solid Tumor Malignancies
Locations
Wesley
Diagnosis
Advanced solid tumours
Open for recruitment
View Trial
J2N-MC-JZNX
J2N-MC-JZNX: A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Locations
Adelaide (Kurralta Park)
Diagnosis
Leukaemia
Open for recruitment
View Trial
JS125-001-I
JS125-001-I: Phase I Study of WJ47156 Monotherapy and in Combination With Other Therapy in Advanced Solid Tumors
Locations
South Brisbane
Diagnosis
Advanced solid tumours
Open for recruitment
View Trial
JSKN033-101
JSKN033-101: JSKN033 in Patients With Advanced or Metastatic Solid Malignant Tumors
Locations
Wesley
Diagnosis
Advanced solid tumours
Trial on hold
View Trial
KATRINA
KATRINA: Pembrolizumab (KeytrudA) in early Triple Negative breast cancer in Australia
Locations
Wesley, Hobart
Diagnosis
Breast cancer
Open for recruitment
View Trial
LEGEND / EG-70-101
LEGEND / EG-70-101: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Locations
Adelaide (Windsor Gardens)
Diagnosis
Bladder cancer
Open for recruitment
View Trial
LIBERATE / ICF19.001
LIBERATE / ICF19.001: Clinical registry of focal low dose rate brachytherapy in men with biopsy confirmed low-intermediate risk prostate cancer
Locations
Epworth Richmond, Epworth Freemasons, Geelong
Diagnosis
Prostate cancer
Open for recruitment
View Trial
LIBERATE
LIBERATE: Clinical registry of focal low dose rate brachytherapy in men with biopsy confirmed low-intermediate risk prostate cancer
Locations
Midland, Rockingham
Diagnosis
Prostate cancer
Open for recruitment
View Trial
LOXO-ENC-23001 / J5A-OX-JZWA
LOXO-ENC-23001 / J5A-OX-JZWA: A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
Locations
Adelaide (Kurralta Park)
Diagnosis
Advanced solid tumours
Open for recruitment
View Trial
LOXO-FRA-24001 / J5E-OX-JZXA
LOXO-FRA-24001 / J5E-OX-JZXA: A Study of LY4170156 in Participants With Selected Advanced Solid Tumors
Locations
South Brisbane
Diagnosis
Advanced solid tumours
Open for recruitment
View Trial
LUNA / CP-MGC026-01
LUNA / CP-MGC026-01: A Study of MGC026 in Participants With Advanced Solid Tumors
Locations
Adelaide (Kurralta Park), Wesley
Diagnosis
Advanced solid tumours
Open for recruitment
View Trial
Lunar-2
LUNAR-2: Pivotal, Randomized, Open-Label Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant with Pembrolizumab and Platinum Based Chemotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer
Locations
Farrer Park, Mount Alvernia
Diagnosis
Lung cancer
Open for recruitment
View Trial
M19-345
M19-345: Study to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Participants With Locally Advanced or Metastatic Solid Tumors
Locations
South Brisbane
Diagnosis
Advanced solid tumours
Open for recruitment
View Trial
MASTERPLAN / CTC 0245
MASTERPLAN / CTC 0245: MFOLFIRINOX And Stereotactic Radiotherapy (SBRT) for Pancreatic Cancer With High Risk and Locally Advanced Disease
Locations
Gold Coast University Hospital
Diagnosis
Pancreatic cancer
Open for recruitment
View Trial
MRDR
MRDR: Myeloma and Related Disease Registry
Locations
Wesley, Adelaide (Kurralta Park)
Diagnosis
Multiple myeloma
Open for recruitment
View Trial
MTX-GPC3-303
MTX-GPC3-303: A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC
Locations
South Brisbane
Diagnosis
Advanced solid tumours
Open for recruitment
View Trial
OLYMPIA-1 / R1979-HM-2298
OLYMPIA-1 / R1979-HM-2298: A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Participants With Follicular Lymphoma
Locations
Wesley
Diagnosis
Lymphoma – B-cell Non Hodgkin’s
Open for recruitment
View Trial
OLYMPIA-3 / R1979-ONC-2105
OLYMPIA-3 / R1979-ONC-2105: A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Patients With Previously Untreated Diffuse Large B-cell Lymphoma
Locations
Wesley
Diagnosis
Lymphoma – B-cell Non Hodgkin’s
Open for recruitment
View Trial
OPTIMA / BCT 2202
OPTIMA / BCT 2202: Optimal personalised treatment of early breast cancer using multiparameter analysis
Locations
Hobart, Adelaide (Kurralta Park), Southport, Wesley
Diagnosis
Breast cancer
Open for recruitment
View Trial
panSOHO / 22752
panSOHO / 22752: A Study to Learn More About How Well Treatment With BAY2927088 Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Locations
Southport
Diagnosis
Advanced solid tumours
Open for recruitment
View Trial
PRIME_LUNG
PRIME_LUNG: Primary Radiotherapy In MEtastatic Lung Cancer – A Pilot Study
Locations
Gold Coast University Hospital
Diagnosis
Lung cancer
Open for recruitment
View Trial
RAMP 301 / VS-6766-301
RAMP 301 / VS-6766-301: A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serious Ovarian Cancer
Locations
Wesley
Diagnosis
Ovarian cancer
Open for recruitment
View Trial
REZILIENT3
Randomized, Controlled, Open-label, Phase 3, Global Multi- Center Trial to Assess the Efficacy and Safety of Zipalertinib plus Chemotherapy versus Chemotherapy alone, in Patients with Previously Untreated, Locally Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer (NSCLC) with Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations
Locations
Farrer Park
Diagnosis
Lung cancer
Open for recruitment
View Trial
Rezilient3
Randomized, Controlled, Open-label, Phase 3, Global MultiCenter Trial to Assess the Efficacy and Safety of Zipalertinib plus Chemotherapy versus Chemotherapy alone, in Patients with Previously Untreated, Locally Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer (NSCLC) with Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations
Locations
Farrer Park
Diagnosis
Lung cancer
Open for recruitment
View Trial
ROSEND
ROSEND: A Randomised trial for the treatment of recalcitrant symptomatic rosacea using definitive volumetric modulated arc radiotherapy or standard dermatological treatment
Locations
Revesby, Gosford, Wahroonga
Diagnosis
Skin cancer – non-melanoma
Trial on hold
View Trial
SB221
SB221: Combination of SON-1010 (IL12-FHAB) and Atezolizumab in Patients With Platinum-resistant Ovarian Cancer
Locations
Adelaide (Kurralta Park)
Diagnosis
Ovarian cancer
Open for recruitment
View Trial
SCTB14-X101
SCTB14-X101: Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB14 in Adult Patients With Advanced Malignant Solid Tumours
Locations
South Brisbane
Diagnosis
Advanced solid tumours
Open for recruitment
View Trial
SGNDV-001
SGNDV-001: Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2
Locations
Chermside
Diagnosis
Urothelial cancer
Open for recruitment
View Trial
SKB264-II-06
SKB264-II-06: SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid Tumors
Locations
Wesley
Diagnosis
Advanced solid tumours
Open for recruitment
View Trial
SLN124-004
SLN124-004: Study to Assess SLN124 in Patients With Polycythemia Vera
Locations
Adelaide (Kurralta Park)
Diagnosis
Myeloproliferative disorders
Open for recruitment
View Trial
SPAR / CTC0138
SPAR / CTC0138: A randomized, placebo-controlled phase II trial of Simvastatin in addition to standard chemotherapy and radiation in preoperative treatment for rectal cancer
Locations
Gold Coast University Hospital
Diagnosis
Colorectal cancer
Open for recruitment
View Trial
STARSTRUCK / 177Lu-TLX250-001
STARSTRUCK / 177Lu-TLX250-001: Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors
Locations
Adelaide (Kurralta Park)
Diagnosis
Advanced solid tumours
Open for recruitment
View Trial
SUNRAY-01 / J3M-MC-JZQB
SUNRAY-01 / J3M-MC-JZQB: A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Locations
Wesley
Diagnosis
Lung cancer
Open for recruitment
View Trial
TRACIE / CO-AU-979-6695
TRACIE / CO-AU-979-6695: TRodelvy use in AdvanCed TrIple Negative BrEast Cancer in Australia
Locations
Townsville, Hobart, Adelaide (Kurralta Park)
Diagnosis
Breast cancer
Open for recruitment
View Trial
TREMOR
TREMOR: Safety and effectiveness of frameless linac-based stereotactic radiosurgery on tremor in patients with essential tremor or Parkinson’s disease
Locations
Epworth Richmond
Diagnosis
Neurological conditions
Open for recruitment
View Trial
TUGETHER / BCT2102
TUGETHER / BCT 2102: Tucatinib Together With Pembrolizumab and Trastuzumab
Locations
Hobart
Diagnosis
Breast cancer
Trial on hold
View Trial
VELOCITY-HNSCC / GS-US-699-7184
VELOCITY-HNSCC / GS-US-699-7184: Study of Novel Treatment Combination Therapies in Participants with Head and Neck Squamous Cell Carcinoma
Locations
Adelaide (Kurralta Park)
Diagnosis
Head and neck cancer
Open for recruitment
View Trial
VIKTORIA-1 / CELC-G-301
VIKTORIA-1 / CELC-G-301: Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer
Locations
Southport
Diagnosis
Breast cancer
Open for recruitment
View Trial
VVD-130850-01
VVD-130850-01: A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130850 in Participants With Advanced Solid and Hematologic Tumors
Locations
South Brisbane
Diagnosis
Advanced solid tumours
Open for recruitment
View Trial
WOMBAT / ANZUP 2201
WOMBAT / ANZUP 2201: Evaluating the efficacy of bipolar androgen therapy in extending metastasis-free survival in patients with M0 castrate-resistant prostate cancer with prostate specific antigen progression but not radiological or clinical progression on darolutamide
Locations
Chermside
Diagnosis
Prostate cancer
Open for recruitment
View Trial
X4P-001-110
X4P-001-110: A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
Locations
Southport
Open for recruitment
View Trial
XPORT-EC-042
XPORT-EC-042: Selinexor in Maintenance Therapy After Systemic Therapy for Participants with P53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma
Locations
Southport
Diagnosis
Endometrial cancer
Open for recruitment
View Trial
XPORT-MF-034
XPORT-MF-034: Study of Selinexor in Combination with Ruxolitinib in Myelofibrosis (SENTRY)
Locations
Wesley
Diagnosis
Myeloproliferative disorders
Open for recruitment
View Trial
ZN-c3-005
ZN-c3-005: A Study of ZN-c3 in Subjects With High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Locations
Chermside
Diagnosis
Ovarian cancer
Trial on hold
View Trial
There are no clinical trials currently available
Become a patient
Find out how to become a patient at Icon Cancer Centre, or request more information from your nearest centre.
Download your free Cancer Diagnosis Checklist
Be more informed and have an active role in your care; download 'Questions to Ask Your Doctor After Cancer Diagnosis'.
Care at Icon
At Icon, care is more than just a word. Our cancer care team are here to support you with compassion, knowledge and hope.
Iconic Community
Our patients share their perspective and advice.